Getting both vaccine doses is key to fighting the delta variant, study shows

The delta variant of the coronavirus has a much easier time evading the neutralizing antibodies produced by COVID-19 vaccines if a person has only gotten one shot, according to a study published July 8 in Nature.

Advertisement

The delta variant is “barely” inhibited by people who have received one dose of the COVID-19 vaccine produced by Pfizer or AstraZeneca, according to the researchers.

However, the study found that the recommended two-dose regimen provides recipients significant protection against the delta variant. This finding echoes a July 7 study published in the New England Journal of Medicine. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.